On November 16, 2022, Michael Sullivan, the Chief Financial Officer of Oragenics, Inc. notified the Company that he would be resigning from the Company, effective December 14, 2022, to pursue other opportunities. Mr. Sullivan has agreed to stay through such date in order to facilitate a smooth and orderly transition of his duties and responsibilities. Mr. Sullivan's resignation was not due to any disagreement with the Company or its Board of Directors on any matter related to its operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -0.98% | -9.01% | -64.10% |
1st Jan change | Capi. | |
---|---|---|
-64.10% | 9.05M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.29% | 21.96B | |
-8.61% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- OGEN Stock
- News Oragenics, Inc.
- Oragenics, Inc. Announces Resignation of Michael Sullivan as Chief Financial Officer, Effective from December 14, 2022